|
Market Cap (16-May) $54,392,152 (781st) |
Close (30-Jun) $0.250 |
Volume (30-Jun) 84,565 |
Shortsold (5-May) 9,746 (0.00%) (586th) |
|
52w High $0.59 |
52w Low $0.083 |
P/E 8.00 |
EPS -0.01 |
MDR released this announcement to the ASX on 17 February 2021, 12:17. The announcement is not marked as price sensitive, and is 1 page(s) in length and 53.65kb in size.
You can view all announcements from MDR and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDR was 0.053% short sold according to ASIC data. It was ranked the 466th most shorted stock on the ASX. It remains ranked 586th as of the latest reported data (05 May 2025).
| Other Recent Announcements from MDR | |
|---|---|
| MDR undertakes strategic review | 22 June 2023, 9:51 |
| Initial Director's Interest Notice - Kate Hill | 29 May 2023, 11:05 |
| Initial Director's Interest Notice - Brett Magun | 29 May 2023, 11:00 |
| Notice of Half-Year Results Briefing | 17 February 2021, 12:17 |
| MDR Quarterly Report & Appendix 4C | 21 January 2021, 9:19 |
| MDR Amended Appendix 3Y - Robert Read | 22 December 2020, 16:46 |
| MDR Appendix 3Y - Christopher Ridd | 22 December 2020, 12:25 |
You must be logged in to post a reply.
MedAdvisor 